FDA NDC Directory · JSON-LD · Markdown

mesalamine

NDC 68382-435 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerZydus Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA203286
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsMESALAMINE (800 mg/1)
Marketing started20180802
Package count2

External sources

Source: openFDA. Public-domain (CC0).